Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/67643
Full metadata record
DC FieldValueLanguage
dc.creatorvieira, mj
dc.creatorsilva, e
dc.creatoroliveira, j
dc.creatorvieira, al
dc.creatordecaro, n
dc.creatordesario, c
dc.creatormuller, a
dc.creatorcarvalheira, j
dc.creatorbuonavoglia, c
dc.creatorthompson, g
dc.date.accessioned2022-09-10T23:43:05Z-
dc.date.available2022-09-10T23:43:05Z-
dc.date.issued2008
dc.identifier.issn1040-6387
dc.identifier.othersigarra:88286
dc.identifier.urihttps://hdl.handle.net/10216/67643-
dc.description.abstractCanine parvovirus (CPV) has been evolving, generating new genetic and antigenic variants throughout the world. This Study was conducted to determine the types of CPV circulating in dogs in Figueira da Foz, Portugal. Thirty fecal samples, collected between 2006 and 2007 from dogs with clinical signs of CPV infection, were tested for CPV by a rapid, in-clinic, enzyme-linked immunosorbent assay (ELISA)/immunomigration test, by conventional real-time polymerase chain reaction (PCR), and by minor-groove binding TaqMan PCR. Of the 29 PCR-positive samples, 15 were identified as CPV-2b and 14 as CPV-2c. No CPV-2a was detected. The sensitivity of the ELISA test was 82.76% compared with the PCR assays. No significant associations were found between CPV type, clinical outcome, breed, vaccination status, or age.
dc.language.isoeng
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.titleCanine parvovirus 2c infection in central Portugal
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Ciências Biomédicas Abel Salazar
dc.identifier.doi10.1177/104063870802000412
dc.identifier.authenticusP-003-Y7V
Appears in Collections:ICBAS - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
88286.pdfVieira et al., 2008144.02 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons